Literature DB >> 29322539

Inhaled corticosteroid use to prevent severe vaso-occlusive episode recurrence in children between 1 and 4 years of age with sickle cell disease: a multicenter feasibility trial.

Leah Vance Utset1, Zalaya Ivy2, Shaina M Willen3, Mark Rodeghier4, Amanda Watt5, Leann Schilling5, Chantel L Jenkins6, Stefanie Pepper7, Barbara Speller-Brown6, Deepika S Darbari6, Suvankar Majumdar7, Olufolake Adisa5, Michael R DeBaun3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29322539      PMCID： PMC5842125          DOI： 10.1002/ajh.25033

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

1.  Airway hyperresponsiveness in children with sickle cell anemia.

Authors:  Joshua J Field; Janet Stocks; Fenella J Kirkham; Carol L Rosen; Dennis J Dietzen; Trisha Semon; Jane Kirkby; Pamela Bates; Sinziana Seicean; Michael R DeBaun; Susan Redline; Robert C Strunk
Journal:  Chest       Date:  2010-08-19       Impact factor: 9.410

Review 2.  The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.

Authors:  Michael R DeBaun; Robert C Strunk
Journal:  Lancet       Date:  2016-06-18       Impact factor: 79.321

3.  Recurrent Acute Chest Syndrome in Pediatric Sickle Cell Disease: Clinical Features and Risk Factors.

Authors:  Gaylen D Patterson; Hafsat Mashegu; Jordan Rutherford; Samantha Seals; David Josey; Cynthia Karlson; Melissa McNaull; Warren May; Clinton Carroll; Frederick E Barr; Suvankar Majumdar
Journal:  J Pediatr Hematol Oncol       Date:  2018-01       Impact factor: 1.289

4.  Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.

Authors:  Jeffrey Glassberg; Caterina Minnitti; Caroline Cromwell; Lawrence Cytryn; Thomas Kraus; Gwen S Skloot; Jason T Connor; Adeeb H Rahman; William J Meurer
Journal:  Am J Hematol       Date:  2017-06-05       Impact factor: 10.047

5.  Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity.

Authors:  Ping An; Emily A Barron-Casella; Robert C Strunk; Robert G Hamilton; James F Casella; Michael R DeBaun
Journal:  J Allergy Clin Immunol       Date:  2011-03-09       Impact factor: 10.793

6.  Increased risk of severe vaso-occlusive episodes after initial acute chest syndrome in children with sickle cell anemia less than 4 years old: Sleep and asthma cohort.

Authors:  Leah D Vance; Mark Rodeghier; Robyn T Cohen; Carol L Rosen; Fenella J Kirkham; Robert C Strunk; Michael R DeBaun
Journal:  Am J Hematol       Date:  2015-03-30       Impact factor: 10.047

7.  Factors predicting future ACS episodes in children with sickle cell anemia.

Authors:  Michael R DeBaun; Mark Rodeghier; Robyn Cohen; Fenella J Kirkham; Carol L Rosen; Irene Roberts; Ben Cooper; Janet Stocks; Olu Wilkey; Baba Inusa; John O Warner; Robert C Strunk
Journal:  Am J Hematol       Date:  2014-08-27       Impact factor: 10.047

8.  Histopathology of experimentally induced asthma in a murine model of sickle cell disease.

Authors:  Sandhya D Nandedkar; Thomas R Feroah; William Hutchins; Dorothee Weihrauch; Kameswari S Konduri; Jingli Wang; Robert C Strunk; Michael R DeBaun; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113
  8 in total
  1 in total

Review 1.  Convergence of Inflammatory Pathways in Allergic Asthma and Sickle Cell Disease.

Authors:  Amali E Samarasinghe; Jason W Rosch
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.